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Summary Over a wide range of pH, the semiquinone free radicals formed by reduction of adriamycin exist
as a form which is strongly stabilised by internal hydrogen bonding and resonance. They protonate with pKa
= 2.9. Below this pH they exhibit absorption maxima at 430nm (smax = 13,200dm3mol-'cm-1) and -720nm
(Cmax=4,200dm3mol3-1 cm-). Above pH 2.9 they have maxima at 480 nm (smax = 14,600dM3mol-1 cm-') and
- 700 nm (Smax =3,400dm mol-cm-'). In acid and alkaline solution the radicals rapidly disappear by
disproportionation, but within the approximate pH range 6 to 11 they appear to be relatively stable for at
least 10-20ms, existing in transient equilibrium with parent adriamycin and the full reduced form. Some rate
constants for the formation and reactions of the semiquinone are given, including the reaction with oxygen to
give 0i-. Fully reduced adriamycin has absorption maxima at 410 nm (smax = 11,000dm3 mol-lcm-') at pH5
and 430 nm (Vmax=19,000dm3mol- cm-) at pH 11. It undergoes decomposition within a few hundred ms.
The intermediates from daunomycin would be expected to have properties similar to those from adriamycin.
Anthracycline antibiotics constitute a major class of
chemotherapeutic agents for the treatment of
different kinds of cancer. Among these, adriamycin
(doxorubicin) has the widest spectrum of clinical
anti-tumour activity (Henry, 1976; Arcamone,
1981). Unfortunately chemotherapy with adria-
mycin is hampered by dose-related cytotoxic and
cardiotoxic effects (Rosen et al., 1974; Green et al.,
1984).
The mechanism of action of adriamycin does not
necessarily involve free radicals (Johnston et al.,
1983). On the other hand, adriamycin, like other
anthracyclines, is known to augment the flow of
electrons from NADPH to molecular oxygen. In
this reaction, an intermediate semiquinone free
radical is formed by interaction with mammalian
microsomes (Sato et al., 1977; Bachur et al., 1978).
From ESR studies (Bachur et al., 1977;
Kalyanaraman et al., 1980) it has been shown that
the semiquinone free radicals may serve to shuttle
the electrons to oxygen, a reaction catalysed by
NADPH-cytochrome P-450 reductase (Bachur et al.,
1979). The radicals could be responsible for the
toxic and/or active principle of adriamycin
chemotherapy. They could be site-specific, binding
to DNA. They could either react directly, or they
could generate other radicals like superoxide (02-)
or hydroxyl (OH'), which could react with the
proximal DNA, producing the strand-scission
reported for adriamycin (Neidle & Waring, 1983)
As well as the semiquinone free radicals, other
unstable one- and two- electron reduced products
may also play an important role in the biological
action of the drug (Sinha & Gregory, 1981).
The ability of adriamycin free radicals to enter
the nucleus and cause specific destruction of
nuclear DNA would depend on their reactivity with
oxygen and other cell constituents and on their
reaction with each other. Since the semiquinones
are expected to be short-lived, the technique of
pulse radiolysis is ideally suited to generate and
study them (Swallow, 1982). The one-electron
reduction potential of adriamycin has already been
investigated by this method (Land et al., 1983a).
The present study was undertaken to determine the
basic physicochemical properties of the semi-
quinone with special emphasis on the optical
absorption, kinetic and stability parameters. Some
properties of the fully reduced form of adriamycin
are also reported. Since adriamycin is chemically
similar to daunomycin, our findings would also be
expected to apply to daunomycin. Our results help
to provide a firm physico-chemical basis on which
speculations about the action of the agents can rest.
Materials and methods
Adriamycin (doxorubicin) hydrochloride was
obtained from Sigma and was used as received. A
medicinal sample of the drug, containing lactose
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additive, was a product of Farmitalia research,
obtained from Montedison Pharmaceuticals Ltd.
Solutions were kept at room temperature for the
minimum period necessary. For experiments in acid
or alkaline solution, the acid (HC1O4) or alkali
(NaOH) were added immediately before the
experiments to minimise any hydrolysis of the
molecule. Necessary stability checks were made
using absorption spectra as well as thin layer
chromatography. Where stock solutions of the drug
were required, they were stored under refrigeration
for the shortest possible time. It has been shown
(Hoffman et al., 1979) that solutions remain stable
under such conditions for months. Water was
redistille,d from alkaline permanganate. All other
chemicals were AnalaR grades from either BDH or
Hopkin and Williams. Solutions were buffered
wherever necessary by borate/OH-, H2PO /HPO2-
or HCOOH/HCOO-. All solutions were purged for
at least 30min using argon, oxygen or oxygen diluted
with nitrogen (all from Air Products Ltd.), or N20
(British Oxygen Company).
For the pulse radiolysis studies, the purged
solutions containing adriamycin, buffer and sodium
formate (10-moldm 3) or formic acid (I mol
dm-3), were passed through a capillary flow system
into a quartz capillary optical cell of - 3mm
diameter and optical path length 1 mm, 1 cm or
2.5cm. An electron beam from the Paterson
Laboratories linear accelerator (Keene, 1972) was
used to irradiate the solution. The changes
produced were analysed within a very short time-scale
(few microseconds to few seconds depending on
the type of study) using an analysing light beam
from a xenon or tungsten lamp. Doses (0.6 to 10Gy,
where 1 Gy = JKg- 1) were such that the concen-
tration of radicals produced was always 5% of
the parent adriamycin or less. Appropriate cut-off
filters were used to avoid photolysis of the
solution by the analysing light. The light coming
through the solution was passed through a Bausch
and Lomb monochromator into an EMI 9558Q
photomultiplier (using band widths of 5 or 10nm)
for wavelengths up to 760nm or a UDT pin 10
photodiode (band widths 20 or 30nm) for wave-
lengths from -700 to 1000nm. Changes in optical
transmission with time were recorded either with a
Polaroid camera fitted to a Tetronix oscilloscope
or on paper print-out using a Commodore PET
2001 computer fitted with a Tektronix 7912 AD
digitiser. Absorbed doses were determined from the
transient (SCN)2- formation from oxygen-saturated
10-2moldm-3 potassium thiocyanate (Adams et al.,
1965), using G (number of molecules of the species
formed per 100eV of absorbed dose) =2.9 and
E500nm=7.1 X 103 dm3mol-
Icm.- 1
A radiometer pHM 62 digital pH meter fitted
with a combined electrode was used for the pH
determinations. Pye Unicam SP 8000 (recording)
and Cecil Instruments CE292 (digital) spectro-
photometers were used for the absorbance
measurements of stable compounds. Curve fittings
and kinetic analyses were carried out using a
Hewlett-Packard 9845A computer fitted with a
Ladd Orthoplex Co-ordinate sensor type 3825-1.
Programmes were written in this laboratory.
Results and discussion
Parent spectra, pKa and dimerisation
Absorption spectra of adriamycin at pH5.7, 11.5
and - 14.3 are shown in Figure 1. Care was taken
to monitor the spectrum in the most alkaline
solution in less than 5min after adding the alkali,
but it is possible that there may have been partial
hydrolysis of the aminosugar group in the solution
(Abdeen et al., unpublished data). However this
should have little effect on the spectrum. The
spectrum at pH 5.7 is that of fully protonated
adriamycin, represented as +HAdH2 where the first
H refers to that on the aminosugar and the other
two to those on the hydroquinone:
0 OH 0
OH
E
0
0
E
E
-0
x
15UU 4UU bUU louu 700
AJnm
Figure 1 Absorption spectra of aqueous solutions of
adriamycin (5.6x 10-5moldm-3), (A) pH5.7; (b)
pH 11.5, (c) pH- 14.3.INTERMEDIATES FROM ADRIAMYCIN 517
Throughout the work we adopt pKa values as
follows (Sturgeon & Schulman, 1977) for the several
possible dissociations. No allowance has been made
for any effect of ionic strength.
+HAdH2=H+ +AdH2, pKa=8.22 (1)
+HAdH2H +H++HAdH-, pKa9.01 (2)
+HAdH-=H+ +AdH-, pKa=9.36 (3)
AdH2H+ +AdH-, pKa= 10.1 (4)
AdH--=H+Ad2, pKa 13.2 (5)
On this view the spectrum at pH 11.5 is that of the
form AdH- and the spectrum at pH- 14.3 is
predominantly that of Ad2-.
Adriamycin and daunomycin undergo associative
dimerisation in aqueous solution (Eksborg, 1978;
Barthelemy-Clavey et al., 1974). The extent of
dimerisation would be expected to depend on pH
and ionic strength, but if the constant Kd defined by
Kd =[Dimer]/[Monomer]2 is taken to be 570-
700dm3mol-1, as on the basis of measurements on
daunomycin by circular dichroism and NMR
(Barthelemy-Clavey et al., 1974). then a typical
solution of 6 x 10-5moldm-3 adriamycin consists
of >90% of the monomeric form so that di-
merisation should not play a major part in the
results reported here.
Difference in absorption between semiquinone and
quinone, and acid dissociation constants
When single pulses of electrons are given to argon-
purged solutions of adriamycin containing high
concentrations of formate or formic acid,
semiquinone free radicals are formed by the
sequence:
(9). The difference between the absorption spectra of
the semiquinone and the quinone was obtained
from measurements after the essential completion of
reactions (6) to (10) but before any significant
radical-radical reaction had time to take place.
Difference spectra for pH 1.1 and 9.1 are shown in
Figure 2. It can be seen that the absorption of the
semiquinone is markedly different from that of the
quinone in the region up to 600nm, and that new
bands appear at >700nm where the quinone does
not absorb at all.
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Figure 2 Difference between absorption spectra of
semiquinone and parent adriamycin measured lOus
after the pulse, [adriamycin]=6.3 x 10-moldm-3
optical path length 1 cm, dose 5.5Gy, (0) pH 1.1
(Imoldm-3 formic acid+H2S04); (0) pH9.1
(10 - Imoldm- formate+borate buffer).
H2O"-H-, OH, e- , H2, H202
OH,(H) +HCO2 (HCO2H)-4CO?2(CO2H )
+H20(H2)
eeq +adriamycin-+semiquinone
(6) The variation with pH of the absorption change
at 475 nm, AA, is shown in Figure 3. Since the
parent does not change in this region, the variation
must be due to a dissociation of the semiquinone.
(7) The points were fitted to the equation:
(8)
CO'- +adriamycin-+semiquinone +CO2 (9)
In N20-saturated solutions, the following reaction
predominates over reaction (8):
H20 (10)
eeq +N20 + N2+OH+OH-
Reaction (10) will be followed by reactions (7) and
AA = + AA2 AA-iopH p_K_+l±lOpK -pH (11)
where AA1 and AA2 are changes in absorbance well
beyond the pKa of the semiquinone. A good fit was
obtained with pKa=2.9+0.05. The pKa is likely to
correspond to dissociation of a proton from the
semiquinone moiety itself rather than the -NH'
group, since the -NH+ group is remote from the
chromophore. Redox analysis shows that the net518 E.J. LAND et al.
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such as those in Figure 2 assuming the yield of
semiquinone to be 6.5 molecules per 100eV. Spectra
for pH 1.1 and 9.1 are given in Figure 4. The
spectra at pH 5 and 12 were identical to that at
pH 9.1. Below 600nm the spectrum of the basic
form is similar to an independently determined
spectrum (Svingen & Powis, 1981) but an additional
broad band is now seen at -700nm. No significant
change in spectrum was observed at pH 5 when the
adriamycin concentration was varied from 2 x 10-5
to 5.5 x 10-4moldm-3 showing no effect of any
association between radicals or between radical and
parent. The presence of lactose (90% w/w), as in
clinical samples of the drug, had no effect on the
spectrum.
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Figure 3 Variation with pH of change in absorbance
at 475 nm produced by pulse, [adriamycin] =5.6 x
10-5moldm-3. The solid line is a computed best fit
(Equation 11) with pKa=2.9.
charge on the semiquinone is zero at pH 7 (Land et
al., 1983a). This is further corroborated by
conductivity measurements (Cercek et al.
unpublished data). Consequently we may write:
+HAdH* =-H++ + +HAdHi
- PKa=2.9 (12)
The pKa of 2.9 is lower than found for most
semiquinones (Swallow, 1982) but is similar to the
value of pKa=2.7 found for the corresponding pKa
of the model compound naphthazarin (Land et al.,
1983b) presumably for the same reason, viz.
extensive delocalisation in the strongly internally
hydrogen-bonded semiquinone structure.
No pKa could be found spectroscopically in the
region 5-12. However by analogy with
naphthazarin (Land et al., 1983b) and quinizarin
(Land et al., in preparation) a further pKa of the
hydroquinone part at pH 14 seems likely. The
-NH+ group of the semiquinone has pKa =9.2
(Land et al., 1983a):
+HAdH'-=H+ +AdH, -,pKa =9.2 (13)
The zwitterionic structure of the semiquinone at
biological pH values will influence transport
through membranes and affect orientation of the
species when in the close vicinity of other molecules
of biological interest.
Absolute absorption spectra ofthe semiquinone
The absolute absorption spectra of the semiquinone
free radicals were obtained from difference spectra
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Figure 4 Absolute absorption spectra of adriamycin
semiquinone obtained from data of Figure 2, (0)
pH 1.1, (-) pH 9.1.
Formation ofthe semiquinone
The rate of reaction between eaq and adriamycin
(reaction 8) was obtained from the rate of
disappearance of e- in solutions containing five
different concentrations of adriamycin (5 x 10-6 to
3xlO-5moldm-3) at pH6.0 (+HAdH2) and 11.5
(AdH-). Allowance was made for reaction of eaq
with other components in the solution. Second
order rate constants were obtained from the
dependence (linear) of the observed first order rate
constant on adriamycin concentration. The
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corresponding rates with CO- (or C02H) were
studied within the concentration range 1 x 10-5 to
9 x 10- 5moldm-3 by monitoring the growth of the
semiquinone absorbance at 380 nm, 475 nm and
720 nm using N20-saturated solutions. Rate con-
stants are included in Table I.
The reaction of hydrogen atoms with adriamycin
was observed in acid solutions (5 x 10-2mol
dm-3H2SO4) containing 10- 'moldm-'t-butyl
alcohol in place of formate. The product of the
reaction had a different spectrum from that of the
reaction of e- or CO'-, no doubt due to extra
reaction possibilities available to hydrogen atoms,
such as addition to the aromatic ring or abstraction
of hydrogen. The rate of the reaction is included in
Table I.
Radical stability
Observations were made at 720 nm, where fully
reduced adriamycin would not be expected to have
a strong absorption and the parent has zero or
negligible absorption. In strongly acid and strongly
alkaline solutions the absorption at 720 nm
decreased in a second order manner attributed to
disproportionation of the semiquinone to yield
parent and fully reduced adriamycin (the hydro-
quinone). The rate constants for the reactions at
pH 1.1 and 13 are included in Table I. Within the
approximate pH range 6 to 11 the absorption at
720 nm at first decreased, and then within one or
two milliseconds attained a value which remained
constant for at least 10-20ms. The residual
absorption was at its highest at pH about 9. This
behaviour is analogous to that seen with naphtha-
zarin (Land et al., 1983c). In the case of naphtha-
zarin the absorption changes were due to the
Table I Rate constants for formation and
semiquinone
attainment of an equilibrium:
2 semiquinone=parent quinone+hydroquinone
(14)
With adriamycin the equilibrium appeared to be
much more to the left than with naphthazarin. For
example after 10-6moldm- radicals had been
introduced into a solution of 5 x 10-5moldm- 3
adriamycin at pH9, the shape and magnitude of the
absorption changes in the range 530-730 nm after
- 20 ms were indistinguishable from that due to the
production of the semiquinone, consistent with the
equilibrium constant for reaction (14) being less
than or equal to 1, so that the radicals did not
decay significantly during the period of
measurement. Unfortunately attempts to explain the
measured pH dependence of the absorption changes
in terms of reaction (14), although successful with
naphthazarin, have not yet succeeded with
adriamycin so that an extra factor must be present.
Nevertheless it is clear that the adriamycin semi-
quinone is rather stable to disproportionation, so
that in biological systems there will be ample scope
for reaction of the semiquinone with components of
the cell remote from the site of origin.
Reaction with oxygen
Adriamycin semiquinone radicals were found to
react rapidly with oxygen at all pH values between
4.5 and 12. Rates for two pH values are given in
Table I. It may be noted that the direction of the
reaction, i.e. virtually complete reaction of the
adriamycin radical with oxygen to produce
superoxide, is different from that seen in non-
reactions of adriamycin
Rate Constant
Reaction pH d3mol- 1s- I
Caq++HAdH2+ HAdH; +H2 6.5 (2.5 +0.3) x 1010
eaq +AdH- -AdH- +OH- 11.5 (1.5+0.2) x 1010
CO2H+ +HAdH2-+CO2+ +HAdH; 1.1 (3.5+0.4) x 109
H-+ +HAdH2-+products 1.1 (2.9+0.3) x 109
COj- + +HAdH2CO2+ +HAdHy- 6.5 (3.4+0.4) x 109
COj- +AdH +H2O- CO2+AdH;- +OH- 11.5 (1.8+0.2) x 108
2+HAdH;-+HAdH2+hydroquinone 1.1 2k=(1.3+0.2) x 109
2AdH'-AdH-(Ad2 )+hydroquinone 13 2k=(5.6± 0.8) x 108
+HAdH- +02 - O7 ++HAdH2 6.0 (3.5+0.4) x 108
AdH-+O2+OH-90j +AdH +H20 11.5 (1.7+0.2) x 108520 E.J. LAND et al.
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Figure 5 Oscilloscope/computer traces showing the formation of fully reduced adriamycin (hydroquinone) by
mutual reaction of semiquinone free radicals. [adriamycin] =4.9 x O-5moldm [formate]=10-lmoldm-,
optical path length 2.5 cm, dose 7Gy. (a) pH 5.0, A=370 nm; (b) pH 5.0; A=400 nm; (c) pH 5.0 A=480 nm; (d)
pH 11.5, A=430nm; (e) pH 11.5, A=480nm; (f) pH 11.5, A=520nm.
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aqueous solution (Afanas'ev et al., 1980). At
biological pH values the reaction may be expressed:
+HAdHW +O2 +HAdH2+O2 (15)
Equation (15) bears directly on a possible mode
of action of adriamycin in which the drug is
enzymically reduced (Arcamone, 1981; Bachur et al.,
1977; Crooke & Reich, 1980; Kalyanaraman et al.,
1980; El Khadem, 1982; Lown et al., 1982b; Muggia
et al., 1982; Neidle & Waring, 1983) to the semi-
quinone and then regenerated by reaction with
oxygen with concomitant formation of superoxide,
0;-, from which hydrogen peroxide and hydroxyl
radicals could arise and cause strand scission of
DNA via abstraction of hydrogen from deoxyribose
residues (Arcamone, 1981; Bates & Winterbourn,
1982; Crooke & Reich, 1980; El Khadem, 1982;
Lown, 1979; Lown et al., 1982a,b; Muggia et al.,
1982; Neidle & Waring, 1983; Winterbourn, 1981b).
Whilst the properties of the quinone and the
semiquinone may be affected by intercalation, and
therefore under these conditions not be precisely
represented by the present work, evidence is ac-
cumulating (Tritton & Yee, 1982) that intercalation
may not be essential for the anti-tumour action of
adriamycin-like quinones. However, although the
semiquinone itself has been implicated
(Winterbourn, 1981a) the present results still point
to a destructive mechanism based on superoxide
formation, and in this respect may be particularly
relevant to adriamycin cardiotoxicity (Green et al.,
1984; Lown et al., 1982a).
Absorption spectrum ofthe hydroquinone
Hydroquinone is present at relatively high
concentration a few ms after delivery of pulses to
solutions at pH values where reaction (14) is largely
to the right. The absorption spectrum of the
hydroquinone was determined at pH 5.0 and 11.5
using the known extinction coefficients of the parent
(sQ) and the semiquinone (i-R) assuming that the
absorption at 720nm is a measure of the
semiquinone concentration, ae. Typical traces are
shown in Figure 5. At any wavelength, the observed
increase in absorbance, AA, is given by:
AA =[aeeR+(R°2 e)HQ-([Qo]-[Qe])EQ]d
(16)
where Ro is the concentration of radicals initially
produced, [Qo] and [Qe] are the initial
concentration of quinone and the concentration of
the quinone at the time ofmeasurement, respectively,
and d is the optical path length. The absorption
spectra obtained are shown in Figure 6. The
principal uncertainty is in ascribing the absorption
at 720nm exclusively to the semiquinone. As the
absorptions at 720nm a few ms after the pulse were
at their highest between pH 6 and - 11 it was not
possible to make a reliable determination of the
absorption spectrum of the hydroquinone at pH
values in this range. However the marked difference
between the spectra at pH 5.0 and 11.5 shows that
the hydroquinone exists in different protonated
forms at these two pH values, so it has at least one
PKa in this region in addition to that of the amino
group, which would not be expected to appreciably
influence the optical absorption.
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Slow elimination ofdaunosaminefrom the
hydroquinone
Changes in absorption were observed for periods
extending to some seconds after delivery of pulses
( -8 Gy) to solutions containing 5x 0-5moldm-
adriamycin and 10-'moldm- formate. At pH 9
the absorptions at 720nm (largely semiquinone),
480nm (parent and semiquinone) and 420nm
(mainly fully reduced form) decreased over
hundreds of milliseconds, yielding species possessing
strong absorptions at 380 and 608 nm. The data522 E.J. LAND et al.
appeared to be consistent with loss of daunosamine
from the hydroquinone, yielding a tautomer of 7-
deoxyadriamycinone, analogous to the
corresponding reaction seen after reduction of
daunomycin in methanol by free radical electron
donors (Kleyer & Koch, 1983). However there
could be an intermediate step. Full spectroscopic
and kinetic data were not obtained, but the results
so far seem to be consistent with a rate constant of
about 5s- ' for the main process at pH9. A
somewhat similar conversion, occurring over a
similar period, could be seen at pH 11.5, except that
there was little semiquinone to disappear along with
the hydroquinone. At pH 5, the rate of conversion
was about a quarter of that seen in the more
alkaline solutions. Further work will be required to
establish the spectra of the tautomer and other
possible intermediates as a function of pH, to
establish a full kinetic scheme and to determine
accurate rate constants.
This work was supported by grants from the Cancer
Research Campaign and the Medical Research Council.
The paper is dedicated to Professor Schulte-Frohlinde on
the occasion of his 60th birthday.
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